ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
20.25
0.145
(0.72%)
Closed November 12 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
20.25
Bid
20.155
Ask
20.90
Volume
2,528
20.205 Day's Range 20.415
0.00 52 Week Range 0.00
Previous Close
20.105
Open
20.345
Last Trade
370
@
20.25
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FBT Latest News

American Stock Exchange Launches Two New Exchange Traded Funds by First Trust Advisors L.P.

NEW YORK, June 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) announced today that it has launched trading in two new exchange-traded funds (ETFs) by First Trust Advisors L.P...

Share Options - Replacement

RNS Number:5920Q Forbidden Technologies PLC 06 October 2003 Forbidden Technologies plc This announcement replaces the Forbidden Technologies plc share options announcement released...

Re Share Option

RNS Number:5788Q Forbidden Technologies PLC 06 October 2003 Forbidden Technologies plc Forbidden Technologies plc ("the Company") announces that on 6th October 2003 under the Company's...

Interim Results

RNS Number:3176Q Forbidden Technologies PLC 30 September 2003 FORBIDDEN TECHNOLOGIES PLC Interim Results for the six months ended 30th June 2003 Forbidden Technologies plc, which has...

Internet Launch

RNS Number:6311P Forbidden Technologies PLC 11 September 2003 FORBIDDEN TECHNOLOGIES PLC Launch of live Internet streaming - FORlive Forbidden Technologies, the company which...

Additional Listing

RNS Number:5516O Forbidden Technologies PLC 12 August 2003 Forbidden Technologies plc ("the Company") announces that it has received applications to exercise options over 1,125,000...

AGM Statement

RNS Number:4647M Forbidden Technologies PLC 18 June 2003 FORBIDDEN TECHNOLOGIES PLC AGM STATEMENT At today's AGM, Vic Steel, Chairman of Forbidden Technologies plc, made the...

Director Shareholding

RNS Number:8769K Forbidden Technologies PLC 08 May 2003 Forbidden Technologies plc Forbidden Technologies plc ("the Company") announces that on Thursday 8 May 2003 under the Company's...

Re Agreement

RNS Number:7683K Forbidden Technologies PLC 07 May 2003 FORBIDDEN TECHNOLOGIES PLC Japanese marketing agreement Forbidden Technologies plc (Forbidden) has reached agreement...

Final Results

RNS Number:4753K Forbidden Technologies PLC 29 April 2003 FORBIDDEN TECHNOLOGIES PLC Preliminary Results for the year ended 31st December 2002 Forbidden Technologies plc, which has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GRNGreenlane Renewables Inc
$ 0.12
(41.18%)
2.29M
NUMINuminus Wellness Inc
$ 0.09
(28.57%)
3.28M
FFH.UFairfax Financial Holdings Limited
US$ 1,350.28
(25.00%)
100
CURACuraleaf Holdings Inc
$ 2.84
(21.89%)
1.24M
SHOPShopify Inc
$ 151.35
(20.72%)
6.32M
FCUFission Uranium Corp
$ 0.72
(-21.74%)
12.55M
COPRCoppernico Metals Inc
$ 0.30
(-18.92%)
1.12M
CSCICOSCIENS Biopharma Inc
$ 3.94
(-17.05%)
5.66k
GMTNGold Mountain Mining Corp
$ 0.05
(-16.67%)
163.8k
MDNAMedicenna Therapeutics Corp
$ 1.78
(-14.01%)
433.56k
ENBEnbridge Inc
$ 58.82
(-1.21%)
16.33M
FCUFission Uranium Corp
$ 0.72
(-21.74%)
12.55M
MFCManulife Financial Corporation
$ 45.39
(0.62%)
8.13M
SUSuncor Energy Inc
$ 53.13
(-1.74%)
7.09M
BITFBitfarms Ltd
$ 3.77
(2.72%)
6.85M

Discussion

View Full Feed
The_Gman The_Gman 3 minutes ago
Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.
NB
ignatiusrielly35 ignatiusrielly35 3 minutes ago
You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.
AVXL
12yearplan 12yearplan 3 minutes ago
Sorry for the late reply; .. from your two links and thanks..
 
Summary.
 
Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f
navycmdr navycmdr 3 minutes ago
https://x.com/InvestIt3/status/1856406733754708460
FNMA
2B_unknown 2B_unknown 3 minutes ago
Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.
NWBO
Hosai Hosai 4 minutes ago
From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even
AVXL
MartinLutherKing MartinLutherKing 4 minutes ago
It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/
ELAB
manibiotech manibiotech 4 minutes ago
Yep nothing for market to be in any FOMO mode 
Likely will slowly go down over next few days without news . As I also said after ASM
ASM
Groveman1 Groveman1 4 minutes ago
Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.
LLBO
FeMike FeMike 5 minutes ago
I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too
NWBO
cottonisking cottonisking 5 minutes ago
No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.
LEHNQ
northam43 northam43 5 minutes ago
Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG
manibiotech manibiotech 6 minutes ago
Look at section subsequent events in 10 q

Hmm
NWBO
jimr1717 jimr1717 6 minutes ago
New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
TSLA
MRJ25 MRJ25 6 minutes ago
Reddit will be better.
FNMA
Rebel13 Rebel13 6 minutes ago
There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!
ELTP
art2426 art2426 7 minutes ago
We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"


How is reading this board, NOT FUN?
BIEL
jimr1717 jimr1717 7 minutes ago
How? Watch and learn.
TSLA
mrwrn2010 mrwrn2010 8 minutes ago
Blast from the past!
ELTP
Mactheriverrat Mactheriverrat 8 minutes ago
Thoughts on TLRY?
TLRY
exwannabe exwannabe 8 minutes ago
Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.
NWBO
gdog gdog 8 minutes ago
11-12 buy/cover EVH $14.19 + 4.15%
MahinAgency MahinAgency 9 minutes ago
H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.
CRDL
againstallodds againstallodds 9 minutes ago
Market expects gold delivery, imagine if no delivery

No gold = no created value
NBRI
CommodityCoverage CommodityCoverage 9 minutes ago
Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond
TTI